Literature DB >> 1701571

Expressive dysphasia possibly related to FK506 in two liver transplant recipients.

J Reyes1, T Gayowski, J Fung, S Todo, M Alessiani, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1701571      PMCID： PMC2966280          DOI： 10.1097/00007890-199012000-00028

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  12 in total

1.  Cyclosporine central neurotoxicity following renal transplantation. Report of a case using magnetic resonance images.

Authors:  S J Scheinman; E R Reinitz; G Petro; R A Schwartz; F S Szmalc
Journal:  Transplantation       Date:  1990-01       Impact factor: 4.939

2.  Acute neurological complications after liver transplantation with particular reference to intraoperative cerebral air embolus.

Authors:  T E Starzl; S A Schneck; G Mazzoni; J A Aldrete; K A Porter; G P Schröter; L J Koep; C W Putnam
Journal:  Ann Surg       Date:  1978-03       Impact factor: 12.969

3.  Liver bypass and the glia.

Authors:  J B Cavanagh
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1974

4.  Aluminium overload, a predisposing condition for epileptic seizures in renal-transplant patients treated with cyclosporin?

Authors:  K P Nordal; T Talseth; E Dahl; A Attramadal; D Albrechtsen; J Halse; E K Brodwall; A Flatmark
Journal:  Lancet       Date:  1985-07-20       Impact factor: 79.321

5.  Liver, kidney, and thoracic organ transplantation under FK 506.

Authors:  S Todo; J J Fung; T E Starzl; A Tzakis; A J Demetris; R Kormos; A Jain; M Alessiani; S Takaya; R Shapiro
Journal:  Ann Surg       Date:  1990-09       Impact factor: 12.969

6.  Kidney transplantation under FK 506.

Authors:  T E Starzl; J Fung; M Jordan; R Shapiro; A Tzakis; J McCauley; J Johnston; Y Iwaki; A Jain; M Alessiani
Journal:  JAMA       Date:  1990-07-04       Impact factor: 56.272

7.  Pontine and extrapontine myelinolysis following liver transplantation. Relationship to serum sodium.

Authors:  Z K Wszolek; R D McComb; R F Pfeiffer; R E Steg; R P Wood; B W Shaw; R S Markin
Journal:  Transplantation       Date:  1989-12       Impact factor: 4.939

8.  Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol.

Authors:  P C de Groen; A J Aksamit; J Rakela; G S Forbes; R A Krom
Journal:  N Engl J Med       Date:  1987-10-01       Impact factor: 91.245

9.  Association between cyclosporin neurotoxicity and hypomagnesaemia.

Authors:  C B Thompson; C H June; K M Sullivan; E D Thomas
Journal:  Lancet       Date:  1984-11-17       Impact factor: 79.321

10.  Central pontine myelinolysis after liver transplantation.

Authors:  C J Estol; A A Faris; A J Martinez; M Ahdab-Barmada
Journal:  Neurology       Date:  1989-04       Impact factor: 9.910
View more
  11 in total

1.  Neurologic complications of FK 506.

Authors:  B H Eidelman; K Abu-Elmagd; J Wilson; J J Fung; M Alessiani; A Jain; S Takaya; S N Todo; A Tzakis; D Van Thiel
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

2.  The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver.

Authors:  K Abu-Elmagd; J J Fung; M Alessiani; A Jain; R Venkataramanan; V S Warty; S Takaya; S Todo; W D Shannon; T E Starzl
Journal:  Transplantation       Date:  1991-07       Impact factor: 4.939

3.  Adverse effects of FK 506 overdosage after liver transplantation.

Authors:  M Alessiani; U Cillo; J J Fung; W Irish; K Abu-Elmagd; A Jain; S Takaya; D Van Thiel; T E Starzl
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

4.  Late onset of progressive speech impairment due to tacrolimus-associated leukoencephalopathy after kidney transplantation.

Authors:  Kazushige Sato; Yuichi Miura; Yuhji Marui; Kiho Tanaka; Shinji Tomikawa
Journal:  Int Urol Nephrol       Date:  2015-06-14       Impact factor: 2.370

5.  Cortical laminar necrosis caused by immunosuppressive therapy and chemotherapy.

Authors:  N Bargalló; M Burrel; J Berenguer; F Cofan; L Buñesch; J M Mercader
Journal:  AJNR Am J Neuroradiol       Date:  2000-03       Impact factor: 3.825

6.  Acute disseminated encephalomyelitis (ADEM) or ADEM-like inflammatory changes in a heart-lung transplant recipient: a case report.

Authors:  M B Horowitz; C Comey; W Hirsch; D Marion; B Griffith; J Martinez
Journal:  Neuroradiology       Date:  1995-08       Impact factor: 2.804

7.  What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients.

Authors:  A Jain; J Reyes; R Kashyap; S Rohal; K Abu-Elmagd; T Starzl; J Fung
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

8.  Reversible tacrolimus-induced neurotoxicity isolated to the brain stem.

Authors:  P J Oliverio; L Restrepo; S A Mitchell; C S Tornatore; S R Frankel
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

9.  Identifying risk factors for central pontine and extrapontine myelinolysis after liver transplantation: a case-control study.

Authors:  Isabelle Morard; Yvan Gasche; Mark Kneteman; Christian Toso; Ariane Mentha; Glenda Meeberg; Gilles Mentha; Norman Kneteman; Emiliano Giostra
Journal:  Neurocrit Care       Date:  2014-04       Impact factor: 3.210

Review 10.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.